1. Home
  2. HLI vs ILMN Comparison

HLI vs ILMN Comparison

Compare HLI & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLI
  • ILMN
  • Stock Information
  • Founded
  • HLI 1972
  • ILMN 1998
  • Country
  • HLI United States
  • ILMN United States
  • Employees
  • HLI N/A
  • ILMN N/A
  • Industry
  • HLI Investment Managers
  • ILMN Medical Specialities
  • Sector
  • HLI Finance
  • ILMN Health Care
  • Exchange
  • HLI Nasdaq
  • ILMN Nasdaq
  • Market Cap
  • HLI 14.4B
  • ILMN 16.0B
  • IPO Year
  • HLI 2015
  • ILMN 2000
  • Fundamental
  • Price
  • HLI $204.42
  • ILMN $100.87
  • Analyst Decision
  • HLI Buy
  • ILMN Buy
  • Analyst Count
  • HLI 8
  • ILMN 15
  • Target Price
  • HLI $205.57
  • ILMN $123.67
  • AVG Volume (30 Days)
  • HLI 386.1K
  • ILMN 1.4M
  • Earning Date
  • HLI 10-29-2025
  • ILMN 11-03-2025
  • Dividend Yield
  • HLI 1.17%
  • ILMN N/A
  • EPS Growth
  • HLI 31.68
  • ILMN N/A
  • EPS
  • HLI 5.94
  • ILMN 7.91
  • Revenue
  • HLI $2,480,866,000.00
  • ILMN $4,284,000,000.00
  • Revenue This Year
  • HLI $13.85
  • ILMN N/A
  • Revenue Next Year
  • HLI $14.49
  • ILMN $2.76
  • P/E Ratio
  • HLI $34.41
  • ILMN $12.76
  • Revenue Growth
  • HLI 23.30
  • ILMN N/A
  • 52 Week Low
  • HLI $137.99
  • ILMN $68.70
  • 52 Week High
  • HLI $208.50
  • ILMN $156.66
  • Technical
  • Relative Strength Index (RSI)
  • HLI 60.12
  • ILMN 53.96
  • Support Level
  • HLI $201.09
  • ILMN $95.12
  • Resistance Level
  • HLI $208.50
  • ILMN $99.56
  • Average True Range (ATR)
  • HLI 4.35
  • ILMN 3.33
  • MACD
  • HLI 0.45
  • ILMN 0.28
  • Stochastic Oscillator
  • HLI 78.32
  • ILMN 67.48

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: